American Journal of Managed Care

1 day ago | ajmc.com | Maggie L. Shaw

On May 9, Japan’s Pharmaceuticals and Medical Devices Agency followed the European Union’s lead in approving rozanolixizumab (Rystiggo; UCB) for generalized myasthenia gravis via self-administration.1,2 Patients in the country now have the option to use a manual push or syringe pump method to administer at home the humanized anti–neonatal Fc receptor monoclonal antibody that targets immunoglobulin G.

1 day ago | ajmc.com | Maggie L. Shaw

With the current standard of care to direct treatment for pulmonary arterial hypertension (PAH) being invasive thermodilution during right heart catheterization, additional methods are needed for routine risk assessment of these patients. A recent analysis of 93 patients with pulmonary hypertension—54 of whom were diagnosed with Group 1 PAH and 39 with chronic thromboembolic pulmonary hypertension—found potential for impedance cardiography to fill this gap.

1 day ago | ajmc.com | Cameron Santoro

Jessica Horwitz, MPH, FNP-C, chief clinical officer at Tia Health, emphasizes the critical need for public health professionals to address the intersectionality of women's health during National Women's Health Week. This involves acknowledging the diverse experiences and unique challenges faced by women across racial, ethnic, socioeconomic, and LGBTQ+ backgrounds, recognizing that health disparities often worsen at these intersections.

1 day ago | ajmc.com | Brooke McCormick

Higher dietary inflammatory index (DII) scores are significantly associated with an increased risk of Alzheimer disease–related death among American adults, according to a study published in Experimental Gerontology.1 Although the exact mechanisms of Alzheimer disease remain unknown, accumulating evidence suggests that chronic inflammation plays a key role in its pathogenesis and progression.2 In particular, past research shows that neuroinflammation accelerates neuronal damage, synaptic...

2 days ago | ajmc.com | Brooke McCormick

Respiratory syncytial virus (RSV)–associated hospitalization rates were significantly lower among infants aged 0 to 7 months during the 2024-2025 RSV season, the first with widespread availability of prevention products, compared with pre–COVID-19 pandemic seasons, according to a recent study in the CDC’s Morbidity and Mortality Weekly Report.1 RSV remains the leading cause of hospitalization among US infants, with those aged 0 to 2 months at the highest risk.2 The researchers highlighted...